✦ LIBER ✦

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance

✍ Scribed by Xinmin Zhao; Xiaofeng Xu; Lin Guo; Joseph Ragaz; Haiyi Guo; Jiong Wu; Zhimin Shao; Ji Zhu; Xiaomao Guo; Jiayi Chen; Beiling Zhu; Zhonghua Wang; Xichun Hu

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 412 KB
Volume: 124
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-1183-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic acid concurrent with either h

Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study

✍ Lale Atahan; Ferah Yıldız; Mustafa Cengiz; Bunyamin Kaplan; Metin Özkan; Gozde Y 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 349 KB

Phase 2 trial of temozolomide using prot

Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases

✍ Raffaele Addeo; Carmine De Rosa; Vincenzo Faiola; Luigi Leo; Gregorio Cennamo; L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views